Tenderwize
Retour à la recherche

Open house Arzneimittelrabattverträge zum Wirkstoff Zidovudin und Lamivudin, ATC J05AR01

AOK Rheinland-Pfalz/Saarland - Die Gesundheitskasse·Eisenberg, Germany·Deadline Mar 31, 2027 · 162 days left·Open·Supplies
Titre original de l'avis

Germany – Pharmaceutical products – Open house Arzneimittelrabattverträge zum Wirkstoff Zidovudin und Lamivudin, ATC J05AR01

30/100

Score d'opportunité

Needs reviewLow complexity
SuppliesOpen
Pourquoi ce score ?

Opportunité

30 / 100

Complexité

20 / 100

Facteurs de risque

The buyer reserves the right to replace open house contracts with exclusive contracts from tenders at any time, resulti...

No estimated value, minimum volume, or discount rate is disclosed. The actual business volume is uncertain.

Analyse approfondie du portefeuille

Analyse approfondie de l'adéquation entreprise

Utilise:

  • Description
  • Industries & Services
  • Capabilities
  • Market & Experience
  • Certifications

Informations clés

Pouvoir adjudicateur
AOK Rheinland-Pfalz/Saarland - Die Gesundheitskasse
Pays
Allemagne
CPV
33600000 - Pharmaceutical products
Date limite
Mar 31, 2027

Aperçu

Moderate opportunity

Faits clés

  • Supplies contract
  • 1 lot
  • Duration until May 2027
  • Supply of pharmaceutical products containing the active substances Zidovudin and Lamivudin (ATC J05AR01) for the German market.
  • Participation in a non-exclusive open house discount agreement scheme.
Afficher le résumé complet

Open house model for non-exclusive discount agreements on pharmaceuticals with active substances Zidovudin and Lamivudin (ATC J05AR01). The AOK Rheinland-Pfalz/Saarland invites all interested pharmaceutical companies to conclude uniform discount contracts without a competitive award procedure. Contracts run for a maximum of 24 months from June 2025, with rolling entry possible at the start of each month. The buyer may replace these agreements with exclusive contracts via tenders. No estimated value or award criteria are specified. This is not a public procurement under EU directive 2014/24.

Risques

The buyer reserves the right to replace open house contracts with exclusive contracts from tenders at any time, resulti...

No estimated value, minimum volume, or discount rate is disclosed. The actual business volume is uncertain.

L'analyse peut être incomplète

Seule une partie des documents de consultation a été analysée. Des exigences, certificats ou documents de soumission supplémentaires peuvent exister dans les documents restants.

Exigences clés

Technical

  • Pharmaceutical products must be authorized and marketable in Germany.
  • Proof of marketability via Lauer-Taxe listing or AMIce database extract.

Administrative

  • Submission of signed contract documents before each desired start date.

Acheteur

Localisation

Eisenberg, DEU

Profil acheteur

Ouvrir le profil

Identifiant

DE271900642

Activité

Health

Lots (1)

LOT-0001

Open house Arzneimittelrabattverträge zum Wirkstoff Zidovudin und Lamivudin, ATC J05AR01

Non-exclusive discount agreements for pharmaceuticals containing Zidovudin and Lamivudin. Uniform terms for all participants. All licensed pharmaceutical companies with marketable products in Germany can join. Contracts start at the earliest on 01.06.2025 and end at the latest on 31.05.2027. Rolling entry possible on the 1st of each month with submission by end of the month preceding the desired start month.

SuppliesEU fundedElectronic submission

Localisation

Eisenberg, Germany

Durée

May 2025 - May 2027

Catégorie

Pharmaceutical products

Date limite

Deadline Mar 31, 2027

Détails de la procédure

Date de publication
10 Apr 2025
Langues
German

Métadonnées de référence

Base juridique
32014L0024

Identifiants de référence

ID de l'appel d'offres
237769-2025

Documents (1)

Appels d'offres similaires